ALHC

ALHC
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $993.695M ▼ | $117.992M ▲ | $3.729M ▼ | 0.375% ▼ | $0.019 ▼ | $15.666M ▼ |
| Q2-2025 | $1.015B ▲ | $110.8M ▼ | $15.667M ▲ | 1.543% ▲ | $0.079 ▲ | $29.863M ▲ |
| Q1-2025 | $926.932M ▲ | $111.425M ▲ | $-9.114M ▲ | -0.983% ▲ | $-0.047 ▲ | $2.244M ▲ |
| Q4-2024 | $701.241M ▲ | $108.89M ▲ | $-31.091M ▼ | -4.434% ▼ | $-0.16 ▼ | $-18.757M ▼ |
| Q3-2024 | $692.433M | $98.511M | $-26.413M | -3.815% | $-0.14 | $-11.814M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $644.08M ▲ | $1.103B ▲ | $940.743M ▲ | $161.871M ▲ |
| Q2-2025 | $503.777M ▲ | $1B ▲ | $859.183M ▲ | $140.967M ▲ |
| Q1-2025 | $479.544M ▲ | $895.617M ▲ | $786.622M ▲ | $108.131M ▲ |
| Q4-2024 | $470.65M ▲ | $782.063M ▲ | $681.108M ▲ | $99.851M ▼ |
| Q3-2024 | $380.976M | $692.287M | $576.66M | $114.55M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.729M ▼ | $144.556M ▲ | $2.315M ▲ | $948K ▼ | $147.819M ▲ | $160.811M ▲ |
| Q2-2025 | $15.653M ▲ | $29.13M ▲ | $-6.664M ▼ | $1.616M ▲ | $24.082M ▲ | $21.127M ▲ |
| Q1-2025 | $-9.354M ▲ | $16.616M ▲ | $-3.462M ▲ | $181K ▼ | $13.335M ▼ | $8.364M ▲ |
| Q4-2024 | $-31.064M ▼ | $-8.711M ▼ | $-5.92M ▲ | $106.875M ▲ | $92.244M ▲ | $-17.995M ▼ |
| Q3-2024 | $-26.429M | $26.19M | $-24.56M | $0 | $1.63M | $16.91M |
Revenue by Products
| Product | Q1-2023 | Q2-2023 | Q3-2023 | Q4-2023 |
|---|---|---|---|---|
Health Care Capitation | $40.00M ▲ | $30.00M ▼ | $30.00M ▲ | $30.00M ▲ |
Health Care Premium | $400.00M ▲ | $420.00M ▲ | $420.00M ▲ | $430.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Alignment Healthcare is a fast‑growing, tech‑enabled Medicare Advantage player that is improving its operating performance but is still loss‑making and cash‑consuming. Its business model is built around using data and AI to manage complex senior populations more proactively than traditional insurers, supported by high‑touch services like home visits and 24/7 concierge support. This creates clear differentiation and the potential for a durable competitive position if quality, satisfaction, and cost metrics remain strong. On the other hand, the company’s declining equity base, reliance on continued improvement in margins and cash flow, and exposure to regulatory and competitive pressures all represent important risks. Overall, it is a growth‑oriented healthcare insurer with promising technology and a focused niche, but with financials that still need to mature toward consistent profitability and stronger balance‑sheet resilience.
NEWS
November 19, 2025 · 8:00 AM UTC
Alignment Healthcare to Present at Piper Sandler 37th Annual Healthcare Conference
Read more
October 14, 2025 · 11:00 AM UTC
Alignment Health Plan and Intermountain Health Launch $0-Premium, 5-star Medicare Advantage Plan for Nevada Seniors
Read more
October 10, 2025 · 8:00 AM UTC
Alignment Healthcare Maintains High 2026 Star Ratings from Medicare, 100% of Members Enrolled in Plans Rated 4 Stars or Higher for Second Consecutive Year
Read more
October 2, 2025 · 8:00 AM UTC
Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025
Read more
October 1, 2025 · 8:00 AM UTC
Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors
Read more
About Alignment Healthcare, Inc.
https://www.alignmenthealthcare.comAlignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $993.695M ▼ | $117.992M ▲ | $3.729M ▼ | 0.375% ▼ | $0.019 ▼ | $15.666M ▼ |
| Q2-2025 | $1.015B ▲ | $110.8M ▼ | $15.667M ▲ | 1.543% ▲ | $0.079 ▲ | $29.863M ▲ |
| Q1-2025 | $926.932M ▲ | $111.425M ▲ | $-9.114M ▲ | -0.983% ▲ | $-0.047 ▲ | $2.244M ▲ |
| Q4-2024 | $701.241M ▲ | $108.89M ▲ | $-31.091M ▼ | -4.434% ▼ | $-0.16 ▼ | $-18.757M ▼ |
| Q3-2024 | $692.433M | $98.511M | $-26.413M | -3.815% | $-0.14 | $-11.814M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $644.08M ▲ | $1.103B ▲ | $940.743M ▲ | $161.871M ▲ |
| Q2-2025 | $503.777M ▲ | $1B ▲ | $859.183M ▲ | $140.967M ▲ |
| Q1-2025 | $479.544M ▲ | $895.617M ▲ | $786.622M ▲ | $108.131M ▲ |
| Q4-2024 | $470.65M ▲ | $782.063M ▲ | $681.108M ▲ | $99.851M ▼ |
| Q3-2024 | $380.976M | $692.287M | $576.66M | $114.55M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.729M ▼ | $144.556M ▲ | $2.315M ▲ | $948K ▼ | $147.819M ▲ | $160.811M ▲ |
| Q2-2025 | $15.653M ▲ | $29.13M ▲ | $-6.664M ▼ | $1.616M ▲ | $24.082M ▲ | $21.127M ▲ |
| Q1-2025 | $-9.354M ▲ | $16.616M ▲ | $-3.462M ▲ | $181K ▼ | $13.335M ▼ | $8.364M ▲ |
| Q4-2024 | $-31.064M ▼ | $-8.711M ▼ | $-5.92M ▲ | $106.875M ▲ | $92.244M ▲ | $-17.995M ▼ |
| Q3-2024 | $-26.429M | $26.19M | $-24.56M | $0 | $1.63M | $16.91M |
Revenue by Products
| Product | Q1-2023 | Q2-2023 | Q3-2023 | Q4-2023 |
|---|---|---|---|---|
Health Care Capitation | $40.00M ▲ | $30.00M ▼ | $30.00M ▲ | $30.00M ▲ |
Health Care Premium | $400.00M ▲ | $420.00M ▲ | $420.00M ▲ | $430.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Alignment Healthcare is a fast‑growing, tech‑enabled Medicare Advantage player that is improving its operating performance but is still loss‑making and cash‑consuming. Its business model is built around using data and AI to manage complex senior populations more proactively than traditional insurers, supported by high‑touch services like home visits and 24/7 concierge support. This creates clear differentiation and the potential for a durable competitive position if quality, satisfaction, and cost metrics remain strong. On the other hand, the company’s declining equity base, reliance on continued improvement in margins and cash flow, and exposure to regulatory and competitive pressures all represent important risks. Overall, it is a growth‑oriented healthcare insurer with promising technology and a focused niche, but with financials that still need to mature toward consistent profitability and stronger balance‑sheet resilience.
NEWS
November 19, 2025 · 8:00 AM UTC
Alignment Healthcare to Present at Piper Sandler 37th Annual Healthcare Conference
Read more
October 14, 2025 · 11:00 AM UTC
Alignment Health Plan and Intermountain Health Launch $0-Premium, 5-star Medicare Advantage Plan for Nevada Seniors
Read more
October 10, 2025 · 8:00 AM UTC
Alignment Healthcare Maintains High 2026 Star Ratings from Medicare, 100% of Members Enrolled in Plans Rated 4 Stars or Higher for Second Consecutive Year
Read more
October 2, 2025 · 8:00 AM UTC
Alignment Healthcare to Announce Third Quarter 2025 Financial Results and Host Conference Call Thursday, Oct. 30, 2025
Read more
October 1, 2025 · 8:00 AM UTC
Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors
Read more

CEO
John E. Kao
Compensation Summary
(Year 2024)

CEO
John E. Kao
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : D+
Most Recent Analyst Grades

Stifel
Buy

B of A Securities
Buy

Baird
Outperform

Keybanc
Overweight

Piper Sandler
Overweight

Stephens & Co.
Overweight

Barclays
Equal Weight

JP Morgan
Neutral

UBS
Neutral
Grade Summary
Price Target
Institutional Ownership

GENERAL ATLANTIC, L.P.
24.287M Shares
$466.558M

VANGUARD GROUP INC
13.969M Shares
$268.336M

BLACKROCK, INC.
13.576M Shares
$260.791M

T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
12.565M Shares
$241.364M

WELLINGTON MANAGEMENT GROUP LLP
11.09M Shares
$213.034M

BLACKROCK INC.
8.19M Shares
$157.332M

FMR LLC
8.081M Shares
$155.24M

CITADEL ADVISORS LLC
6.165M Shares
$118.434M

HOOD RIVER CAPITAL MANAGEMENT LLC
5.917M Shares
$113.674M

PRICE T ROWE ASSOCIATES INC /MD/
5.573M Shares
$107.061M

MILLENNIUM MANAGEMENT LLC
5.492M Shares
$105.495M

INVESCO LTD.
4.467M Shares
$85.804M

GEODE CAPITAL MANAGEMENT, LLC
3.542M Shares
$68.05M

STATE STREET CORP
3.208M Shares
$61.634M

VOYA INVESTMENT MANAGEMENT LLC
3.196M Shares
$61.401M

RENAISSANCE TECHNOLOGIES LLC
2.973M Shares
$57.102M

8 KNOTS MANAGEMENT, LLC
2.893M Shares
$55.576M

POINT72 ASSET MANAGEMENT, L.P.
2.825M Shares
$54.272M

BROAD BAY CAPITAL MANAGEMENT, LP
2.375M Shares
$45.621M

NEXT CENTURY GROWTH INVESTORS LLC
2.273M Shares
$43.659M
Summary
Only Showing The Top 20

